MEDIPOST Co., Ltd. (078160.KQ)
KRW 12000.0
(-11.37%)
KRW 12000.0
(-11.37%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 52.33 Billion KRW | -56.59% |
| 2022 | 120.56 Billion KRW | 303.98% |
| 2021 | 29.84 Billion KRW | -28.07% |
| 2020 | 41.49 Billion KRW | 16.71% |
| 2019 | 35.55 Billion KRW | 127.96% |
| 2018 | 15.59 Billion KRW | 0.0% |
| 2017 | 15.59 Billion KRW | 0.0% |
| 2016 | 15.59 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 46.16 Billion KRW | -11.65% |
| 2024 Q1 | 52.25 Billion KRW | -0.17% |
| 2023 Q1 | 123.14 Billion KRW | 2.14% |
| 2023 Q4 | 52.33 Billion KRW | -36.06% |
| 2023 Q3 | 81.85 Billion KRW | -34.69% |
| 2023 Q2 | 125.33 Billion KRW | 1.78% |
| 2023 FY | 52.33 Billion KRW | -56.59% |
| 2022 Q2 | 127.38 Billion KRW | 322.27% |
| 2022 Q1 | 30.16 Billion KRW | 1.08% |
| 2022 Q3 | 116.75 Billion KRW | -8.35% |
| 2022 Q4 | 120.56 Billion KRW | 3.26% |
| 2021 Q4 | 29.84 Billion KRW | 2.71% |
| 2021 Q3 | 29.05 Billion KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| HLB Co., Ltd. | 62.7 Billion KRW | 16.534% |
| iNtRON Biotechnology, Inc. | 402.9 Million KRW | -12889.946% |
| BINEX Co., Ltd. | 53.5 Billion KRW | 2.186% |
| Bioneer Corporation | 44.63 Billion KRW | -17.244% |
| Anterogen.Co.,Ltd. | 9.74 Billion KRW | -437.326% |
| CrystalGenomics, Inc. | 32 Billion USD | -63.539% |
| Helixmith Co., Ltd | 20.22 Billion KRW | -158.743% |
| Chabiotech Co.,Ltd. | 449.63 Billion KRW | 88.36% |
| Medy-Tox Inc. | 82.83 Billion KRW | 36.813% |
| Peptron, Inc. | 9.13 Billion KRW | -473.063% |
| Amicogen, Inc. | 149.59 Billion KRW | 65.014% |
| Genexine, Inc. | 67.42 Billion KRW | 22.379% |
| HLB Therapeutics Co.,Ltd. | 10.02 Billion KRW | -422.21% |
| LegoChem Biosciences, Inc. | 12.64 Billion KRW | -313.935% |
| ALTEOGEN Inc. | 83.76 Billion KRW | 37.521% |
| PharmaResearch Co., Ltd. | 34.3 Billion KRW | -52.558% |
| SillaJen, Inc. | 9.69 Billion KRW | -439.752% |
| JETEMA, Co., Ltd. | 130.49 Billion KRW | 59.894% |
| OliX Pharmaceuticals,Inc | 39.35 Billion KRW | -32.981% |
| Genomictree Inc. | 1.83 Billion KRW | -2752.724% |
| MedPacto, Inc. | 8.6 Billion KRW | -508.287% |
| D&D Pharmatech | 8.13 Billion KRW | -543.42% |
| EASY BIO,Inc. | 82.27 Billion KRW | 36.389% |
| GI Innovation, Inc. | 3.72 Billion KRW | -1306.614% |